Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry

Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry

Abstract Objectives The CytoSorb therapy in COVID-19 (CTC) registry evaluated the clinical performance and treatment parameters of extracorporeal hemoadsorption integrated with veno-venous extracorporeal membrane oxygenation (VV ECMO) in critically ill COVID-19 patients with acute respiratory distre...

Full description

Bibliographic Details
Main Authors: J. W. Awori Hayanga, Tae Song, Lucian Durham, Lawrence Garrison, Deane Smith, Zsolt Molnar, Joerg Scheier, Efthymios N. Deliargyris, Nader Moazami
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Critical Care
Subjects:
Coronavirus—COVID-19
ECMO—Extracorporeal membrane oxygenation
ICU—Intensive care unit
ARDS—Acute respiratory distress syndrome
Mortality
Inflammation
Online Access:https://doi.org/10.1186/s13054-023-04517-3

Internet

https://doi.org/10.1186/s13054-023-04517-3

Similar Items